Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley B Cohen

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Nature Reviews. Rheumatology|September 12, 2012
Rheumatoid arthritis: Threshold for success in RA drug developmentStanley B Cohen
Rheumatic Diseases Clinics of North America|November 29, 2016
Malignancy and Janus Kinase InhibitionPadmapriya Sivaraman, Stanley B Cohen
Open Access Rheumatology : Research and Reviews|November 6, 2023
Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast]Stanley B Cohen, Mariah Z Leach
The Journal of Rheumatology|August 1, 2025
Denosumab for Osteoporosis Treatment in Rheumatic Diseases: What Do We Know 15 Years Post Approval?Stanley B Cohen, Kenneth G Saag
Immunotherapy|September 6, 2022
Plain language summary of the VOLTAIRE-RA in patients with moderate-to-severe rheumatoid arthritisStanley B Cohen, Eric C Lee
Nature Reviews. Rheumatology|March 23, 2022
Oral surveillance and JAK inhibitor safety: the theory of relativityKevin L Winthrop, Stanley B Cohen
Arthritis and Rheumatism|June 3, 2008
The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the roadJoan M Bathon, Stanley B Cohen
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2021
Use of Precision Medicine to Guide Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et alStanley B Cohen, Theodore Mellors, Martin J Bergman
The Journal of Rheumatology|February 4, 2003
Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritisStanley B Cohen, J Michael Woolley, Wing Chan, et al.
Seminars in Arthritis and Rheumatism|October 27, 2004
Immune-mediated inner ear disease: 10-year experienceShelley S Broughton, William E Meyerhoff, Stanley B Cohen
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Nature Reviews. Rheumatology|September 12, 2012
Rheumatoid arthritis: Threshold for success in RA drug developmentStanley B Cohen
Rheumatic Diseases Clinics of North America|November 29, 2016
Malignancy and Janus Kinase InhibitionPadmapriya Sivaraman, Stanley B Cohen
Open Access Rheumatology : Research and Reviews|November 6, 2023
Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast]Stanley B Cohen, Mariah Z Leach
The Journal of Rheumatology|August 1, 2025
Denosumab for Osteoporosis Treatment in Rheumatic Diseases: What Do We Know 15 Years Post Approval?Stanley B Cohen, Kenneth G Saag
Immunotherapy|September 6, 2022
Plain language summary of the VOLTAIRE-RA in patients with moderate-to-severe rheumatoid arthritisStanley B Cohen, Eric C Lee
Nature Reviews. Rheumatology|March 23, 2022
Oral surveillance and JAK inhibitor safety: the theory of relativityKevin L Winthrop, Stanley B Cohen
Arthritis and Rheumatism|June 3, 2008
The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the roadJoan M Bathon, Stanley B Cohen
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2021
Use of Precision Medicine to Guide Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et alStanley B Cohen, Theodore Mellors, Martin J Bergman
The Journal of Rheumatology|February 4, 2003
Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritisStanley B Cohen, J Michael Woolley, Wing Chan, et al.
Seminars in Arthritis and Rheumatism|October 27, 2004
Immune-mediated inner ear disease: 10-year experienceShelley S Broughton, William E Meyerhoff, Stanley B Cohen
Pageof 8